ResMed Inc. (RMD)
NYSE: RMD · Real-Time Price · USD
243.78
+0.18 (0.07%)
Nov 22, 2024, 4:00 PM EST - Market closed
ResMed Employees
ResMed had 9,980 employees as of June 30, 2024. The number of employees decreased by 160 or -1.58% compared to the previous year.
Employees
9,980
Change (1Y)
-160
Growth (1Y)
-1.58%
Revenue / Employee
$481,712
Profits / Employee
$111,511
Market Cap
35.77B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Jun 30, 2024 | 9,980 | -160 | -1.58% |
Jun 30, 2023 | 10,140 | 1,980 | 24.26% |
Jun 30, 2022 | 8,160 | 190 | 2.38% |
Jun 30, 2021 | 7,970 | 200 | 2.57% |
Jun 30, 2020 | 7,770 | 530 | 7.32% |
Jun 30, 2019 | 7,240 | 1,300 | 21.89% |
Jun 30, 2018 | 5,940 | -140 | -2.30% |
Jun 30, 2017 | 6,080 | 830 | 15.81% |
Jun 30, 2016 | 5,250 | 910 | 20.97% |
Jun 30, 2015 | 4,340 | 240 | 5.85% |
Jun 30, 2014 | 4,100 | 200 | 5.13% |
Jun 30, 2013 | 3,900 | 200 | 5.41% |
Jun 30, 2012 | 3,700 | 250 | 7.25% |
Jun 30, 2011 | 3,450 | 250 | 7.81% |
Jun 30, 2010 | 3,200 | 300 | 10.34% |
Jun 30, 2009 | 2,900 | 200 | 7.41% |
Jun 30, 2008 | 2,700 | 0 | - |
Jun 30, 2007 | 2,700 | 200 | 8.00% |
Jun 30, 2006 | 2,500 | 573 | 29.74% |
Jun 30, 2005 | 1,927 | 407 | 26.78% |
Jun 30, 2004 | 1,520 | 56 | 3.83% |
Jun 30, 2003 | 1,464 | 214 | 17.12% |
Jun 30, 2002 | 1,250 | 297 | 31.16% |
Jun 30, 2001 | 953 | 348 | 57.52% |
Jun 30, 2000 | 605 | 104 | 20.76% |
Jun 30, 1999 | 501 | 111 | 28.46% |
Jun 30, 1998 | 390 | 106 | 37.32% |
Jun 30, 1997 | 284 | 55 | 24.02% |
Jun 30, 1996 | 229 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
IQVIA Holdings | 87,000 |
Humana | 67,600 |
Centene | 67,000 |
GE HealthCare Technologies | 51,000 |
Edwards Lifesciences | 19,800 |
Agilent Technologies | 18,100 |
IDEXX Laboratories | 11,000 |
Veeva Systems | 7,172 |
RMD News
- 18 days ago - ResMed Announces Participation in the UBS Global Healthcare Conference - GlobeNewsWire
- 20 days ago - My Top 15 High-Growth Dividend Stocks For November 2024 - Seeking Alpha
- 4 weeks ago - Sleep Apnea Device Maker ResMed Is A Durable MedTech, With Positive Fundamentals, Says Analyst - Benzinga
- 4 weeks ago - ResMed Inc. (RMD) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 4 weeks ago - ResMed beats quarterly profit estimates on strong demand for its sleep apnea devices - Reuters
- 7 weeks ago - ResMed to Report First Quarter Fiscal 2025 Earnings on October 24, 2024 - GlobeNewsWire
- 7 weeks ago - My Top 15 High Growth Dividend Stocks For October 2024 - Seeking Alpha
- 7 weeks ago - ResMed Unveils 2030 Strategy to Drive Growth, Profitability, and Shareholder Returns - GlobeNewsWire